FdaApplication
BLA 103764
Identifiers
- fda_app_no: BLA103764
Properties
| Property | Value |
|---|---|
| applicant_name | Novartis Pharmaceuticals Corporation |
| application_type | BLA |
| approval_date | 1998-05-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SIMULECT | BASILIXIMAB | 20MG | VIAL;SINGLE-USE |
| SIMULECT | BASILIXIMAB | 10MG | VIAL;SINGLE-USE |
2 products